Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer

NCT04857619 · clinicaltrials.gov ↗

COMPLETED

Status

763

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

OTHER: None (Observational study)

Sponsor

AstraZeneca

Collaborators

[object Object]